Predictive value of N-terminal-Pro brain natriuretic peptide in the detection of coronary artery disease in patients with positive myocardial perfusion imaging
- PMID: 31086793
- PMCID: PMC6504941
- DOI: 10.34171/mjiri.33.14
Predictive value of N-terminal-Pro brain natriuretic peptide in the detection of coronary artery disease in patients with positive myocardial perfusion imaging
Abstract
Background: N-terminal pro-brain natriuretic peptide (NT-ProBNP) increases during myocardial ischemia and has a potential for the diagnosis of patients with coronary artery disease (CAD). We aimed to determine the incremental diagnostic value of NT-ProBNP in the selection of patients with positive myocardial perfusion imaging (MPI) for coronary angiography. We also tested the association between the level of NT-ProBNP and severity of CAD based on the vessel score and Gensini score. Methods: In this cross-sectional study, stable angina patients with positive MPI who were assessed by coronary angiography in Imam Khomeini Hospitalwere enrolled. After the collection of demographic and clinical data, NT-ProBNP was measured in all patients on the day of coronary angiography, and its association with the presence of CAD, vessel score and Gensini score was tested. Results: We enrolled 170 patients (mean age61.2±10.1 years, 86 males (50.6%)). Seventy-two (42.3%) patients had at least one stenotic vessel. NT-Pro BNP was significantly higher in the CAD-positive group (OR=1.01, 95% CI: 1.00-1.02; p=0.008) and could independently predict the presence of CAD at a cut-off point of 69.5, with a sensitivity of 55.6%, specificity of 82.5% and diagnostic accuracy of 61.7%. The Gensini score had a modest correlation with NT-Pro BNP (r=0.60, p<0.001). The combination of MPI result and NT-Pro BNP could predict the presence of CAD (OR=14.57, 95% CI: 4.28, 49.56; p<0.001). Conclusion: Serum level of NT-Pro BNP alone and its combination with the results of MPI can significantly predict the presence of CAD and therefore, highlights the need for performing coronary angiography.
Keywords: Coronary angiography; Coronary artery disease; Diagnosis; Myocardial perfusion imaging; NT-Pro brain natriuretic peptide.
References
-
- Mack M, Gopal A. Epidemiology, traditional and novel risk factors in coronary artery disease. Heart Fail Clin. 2016;12:1–10. - PubMed
-
- Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA. et al. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/ SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, Circulation. 2016;134:e123–e155. - PubMed
-
- Gaddipati V, Elsayed A, Kip K, Diwadkar S, Chae S, Berlowitz M. Understanding Diagnostic Factors Predicting Negative Coronary Angiography in Patients With Suspected Ischemic Heart Disease: Can We Prevent the Cost of Unnecessary Procedures? Am Heart Assoc. 2017;10(3):A033.
-
- Morrissey RP, Rana JS. Biomarkers and Assessment of Subclinical Atherosclerosis for the Prediction of Cardiovascular Disease: What is the Current Evidence? Curr Cardiovasc Risk Rep. 2013;7:108–112.
-
- Sotoudeh Anvari M, Karimi M, Shafiee A, Boroumand M, Bozorgi A, Sedaghat R. et al. Complementary Diagnostic Value of Heart Type Fatty Acid-binding Protein in Early Detection of Acute Myocardial Infarction. Crit Pathw Cardiol. 2018;17:43–46. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous